Reinhard Lührmann

Title: Reinhard Lührmann: Innovator in Biochemical Detection

Introduction

Reinhard Lührmann is a notable inventor based in Marburg, Germany. He has made significant contributions to the field of biochemistry, particularly in the detection of specific reactions related to systemic lupus erythematosus. With a total of 2 patents, his work has implications for both diagnosis and treatment of various diseases.

Latest Patents

Lührmann's latest patents include a test system for detecting a splicing reaction and the use of methylated, SMD homologous peptides. These peptides are reactive with antibodies found in the sera of living beings affected by systemic lupus erythematosus. His invention details a method for producing certain peptides that contain methylated arginines, which are crucial for reacting with these antibodies. This innovation not only aids in diagnosis but also has potential applications in the treatment of systemic lupus erythematosus and related diseases.

Career Highlights

Throughout his career, Reinhard Lührmann has worked with prominent companies such as Aventis Research & Technologies GmbH & Co. KG and Innogenetics N.V. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of biochemistry.

Collaborations

Lührmann has collaborated with notable colleagues, including Christoph Hüls and Bettina Bauer. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Reinhard Lührmann's contributions to the field of biochemistry through his patents and collaborations highlight his role as an innovator. His work continues to impact the diagnosis and treatment of diseases, showcasing the importance of innovation in healthcare.